Skip to main content

Bank of New York Mellon Corp

Bank

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1390777 NEW YORK, NY

Position in ESPR

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$0
+$0 QoQ
Shares Held
732,616
+32.0% QoQ
Ownership
0.285%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 77% Shared 0% None 23%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $1,289,702,180 across 44 Drug Manufacturers - Specialty & Generic names. ESPR ranks #44 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 732,616
2026-03-31 555,177
2025-12-31 549,094
2025-09-30 463,088
2025-06-30 427,057
2025-03-31 415,141
2024-12-31 427,532
2024-09-30 425,774
2024-06-30 572,323
2024-03-31 16,941
2023-12-31 65,134
2023-09-30 27,396
2023-06-30 27,558
2023-03-31 284,940
2022-12-31 286,286
2022-09-30 272,406
2022-06-30 241,189
2022-03-31 224,222
2021-12-31 111,328
2021-09-30 92,049
2021-06-30 83,757
2021-03-31 101,292
2020-12-31 118,017
2020-09-30 136,073
2020-06-30 137,479
2020-03-31 137,239